Medtronic recalls MiniMed 670G insulin pumps (MMT-1760 to MMT-1782) due to potential insulin over- or under-delivery when pump height changes, risking severe hypoglycemia or hyperglycemia.
All Medtronic MiniMed infusion pumps (Paradigm series, 600 series, and BLE 700 series) were found to be affected by unintended over- and under-delivery of insulin when the pump is elevated or lowered relative to the infusion site, respectively, because of changes in gravitational force impacting hydrostatic and hydrodynamic pressures. Insulin over-delivery, which can occur when the pump is elevated relative to the infusion site, can result in severe hypoglycemia, altered mental status, seizure, coma, or death. An under-delivery of insulin, which can occur at lowered pump height conditions relative to the infusion site, can result in severe hyperglycemia, dehydration, diabetic ketoacidosis, or death.
Medtronic is recalling specific models of MiniMed 670G insulin pumps because they can deliver too much or too little insulin when the pump is moved up or down relative to the body. This could cause life-threatening low blood sugar or high blood sugar conditions.
When the insulin pump is elevated above the infusion site, it can deliver too much insulin, causing severe hypoglycemia (dangerously low blood sugar) that may lead to seizures, coma, or death. When the pump is lowered below the infusion site, it can deliver too little insulin, causing severe hyperglycemia (dangerously high blood sugar) that may lead to dehydration or diabetic ketoacidosis.
People with diabetes who use Medtronic MiniMed 670G insulin pumps (model numbers MMT-1760 through MMT-1782) are affected. Those who have recently had their pump height changed during use are at higher risk.
Check your pump's model number on the device or in the user guide. The affected models are MMT-1760, MMT-1761, MMT-1762, MMT-1780, MMT-1781, and MMT-1782. These pumps were sold with specific serial numbers listed in the recall notice.
Look for the model number on your pump or in the user guide to confirm if it's one of the recalled models (MMT-1760 to MMT-1782).
If you have the recalled pump, check your blood sugar more frequently than usual to detect signs of hypoglycemia or hyperglycemia.
The affected models are MiniMed 670G insulin pumps with model numbers MMT-1760, MMT-1761, MMT-1762, MMT-1780, MMT-1781, and MMT-1782.
Yes, insulin over-delivery can cause severe hypoglycemia leading to seizures, coma, or death, and under-delivery can cause severe hyperglycemia leading to dehydration or diabetic ketoacidosis.
No, but you should monitor blood sugar levels closely and check your pump model to see if it's affected. The recall does not require immediate discontinuation but requires caution.
We’ve drafted a message you can send Medtronic to request your refund or repair — edit it as you like.
Subject: Recall Z-1739-2026 — Medtronic Medtronic Hello, I own a Medtronic that is covered by recall Z-1739-2026 from Medtronic. I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this? Thank you.
Experiences, tips, and questions from readers. Every comment is reviewed before it appears.
No comments yet — be the first to share your experience.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
